32 results match your criteria: "Metro Health University of Michigan Health[Affiliation]"

The benefits of a low dose complex carbohydrate/citrulline electrolyte solution for preoperative carbohydrate loading: Focus on glycemic variability.

Am J Surg

March 2018

West Michigan Surgical Specialists LLC, Grand Rapids, MI, USA; Clinical Chief, Division of Colorectal Surgery Mercy Health St Mary's Hospital, Grand Rapids, MI, USA; Clinical Assistant Professor Michigan State University College of Osteopathic Medicine, Department of Osteopathic Surgical Specialties, USA; Clinical Assistant Professor Michigan State University College of Human Medicine, USA.

Background: Perioperative insulin resistance is associated with significant hyperglycemia-related morbidity in patients undergoing major surgery. We sought to assess the effect of preoperative loading with a low-dose maltodextrin/citrulline solution compared to a commercially available sports drink on glycemic levels in an established colorectal enhanced recovery program.

Methods: Retrospective analysis was undertaken of elective non-diabetic colectomies and enterectomies from January 2016-March 2017.

View Article and Find Full Text PDF

Aim: The incremental cost of peripheral orbital atherectomy system (OAS) plus balloon angioplasty (BA) versus BA-only for critical limb ischemia was estimated.

Materials & Methods: A deterministic simulation model used clinical and healthcare utilization data from the CALCIUM 360° trial and current cost data. Incremental cost of OAS + BA versus BA-only included differential utilization during the procedure and adverse-event costs at 3, 6 and 12-months.

View Article and Find Full Text PDF

Background: Usual practice in community health-care settings indicates that arterial catheters are inserted by physicians. In the context of a respiratory therapist (RT)-managed arterial catheter placement protocol being implemented in our community hospital, the current study describes the implementation and outcomes of this RT-managed arterial catheter insertion and maintenance program.

Methods: Tuality Healthcare is a 215-bed community health-care system (10-bed ICU) in Hillsboro, Oregon.

View Article and Find Full Text PDF

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.

Circulation

September 2017

From Icahn School of Medicine at Mount Sinai, New York City (P.K., P.F.); Division of Cardiovascular Medicine, Emory University Hospital, Atlanta, GA (K.N.); Mission Cardiovascular Research Institute, Fremont, CA (A.J.); North Carolina Heart and Vascular, UNC-Rex Healthcare, Raleigh (R.S.); Pinnacle Health Cardiovascular Institute, Harrisburg, PA (W.B.B.); Yuma Cardiology Associates, Yuma Regional Medical Center, AZ (J.C.); Department of Angiology, Hanusch Hospital, Vienna, Austria (M.W.); Division of Angiology, Medical University Graz, Austria (M.B.); Metro Health University of Michigan Health, Wyoming, MI (J.A.M.); Yale University School of Medicine, New Haven, CT (C.M.-H.); VasCore, Massachusetts General Hospital, Boston (M.R.J.); Department of Interventional Radiology, Auckland City Hospital, New Zealand (A.H.H.); and Department of Vascular Surgery, Cleveland Clinic, OH (S.P.L.).

Background: Drug-coated balloons (DCBs) are a predominant revascularization therapy for symptomatic femoropopliteal artery disease. Because of the differences in excipients, paclitaxel dose, and coating morphologies, varying clinical outcomes have been observed with different DCBs. We report the results of 2 studies investigating the pharmacokinetic and clinical outcomes of a new DCB to treat femoropopliteal disease.

View Article and Find Full Text PDF

Purpose Of Review: Retrograde tibiopedal access and interventions have contributed to advance of endovascular techniques to treat critical limb ischemia (CLI) patients. This review encompasses the spectrum from advanced diagnostic imaging and technical therapeutic approaches for infrapopliteal occlusions, to a discussion of current standards and future directions.

Recent Findings: Contemporary studies of infrapopliteal angioplasty show suboptimal short-term and 1-year clinical outcomes.

View Article and Find Full Text PDF

Introduction: While studies have documented racial and ethnic disparities in amputation rates for patients with peripheral artery disease (PAD), the importance of specific factors has not been quantified. This research seeks to provide such evidence and to quantify how much of the difference reflects observable versus unexplained factors.

Methods: This study used the nationally representative HCUP inpatient database from 2006 to 2013 for patients with a primary diagnosis of PAD who were either Caucasian, African-American, or Hispanic.

View Article and Find Full Text PDF